Hiroaki Nishimatsu

Memorial Hospital of South Bend — United States

Medicine · Health Sciences

40h-index6.2kcitations210works2.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(46), Urinary and Genital Oncology Studies(31), Urinary Bladder and Prostate Research(28), Neuropeptides and Animal Physiology(22), Prostate Cancer Treatment and Research(21)

Publications209 total

Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis
International Journal of Urology·2024· 3 citedOpen Access
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis
2024· 2 citedOpen Access
Enfortumab vedotin versus platinum rechallenge in post‐platinum, post‐pembrolizumab advanced urothelial carcinoma: A multicenter propensity score‐matched study
International Journal of Urology·2023· 26 citedOpen Access
Validation of a Drug-Based Score in Advanced Urothelial Carcinoma Treated with Pembrolizumab
Immunotherapy·2023· 7 cited
Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study
World Journal of Urology·2023· 5 cited
Improved survival in real‐world patients with advanced urothelial carcinoma: A multicenter propensity score‐matched cohort study comparing a period before the introduction of pembrolizumab (2003–2011) and a more recent period (2016–2020)
International Journal of Urology·2022· 16 citedOpen Access
Incomplete sagittal septum of the bladder with cystolithiasis
IJU Case Reports·2022Open Access
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
Journal for ImmunoTherapy of Cancer·2022· 30 citedOpen Access
Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
Scientific Reports·2021· 24 citedOpen Access
Prognostic Significance of the Albumin-to-globulin Ratio for Advanced Urothelial Carcinoma Treated with Pembrolizumab: A Multicenter Retrospective Study
Research Square (Research Square)·2021Open Access
Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study
Japanese Journal of Clinical Oncology·2021· 9 cited
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
International Journal of Clinical Oncology·2020· 17 citedOpen Access
Abstract 1309: Distinct molecular subtypes and a high diagnostic urinary biomarker of upper urinary tract urothelial carcinoma
Cancer Research·2020
Rare gastrointestinal stromal tumor in an ileal conduit detected by recurrent massive bleeding from the stoma
IJU Case Reports·2020· 2 citedOpen Access
Histone methylation and demethylation are implicated in the transient and sustained activation of the interleukin-1β gene in murine macrophages
Heart and Vessels·2020· 7 cited
Distinct molecular subtypes and a high diagnostic urinary biomarker of upper urinary tract urothelial carcinoma
European Urology Open Science·2020Open Access
PD18-11 DISTINCT MOLECULAR SUBTYPES AND A HIGH DIAGNOSTIC URINARY BIOMARKER OF UPPER URINARY TRACT UROTHELIAL CARCINOMA
The Journal of Urology·2020
Nonischemic or Ischemic Laparoscopic Partial Nephrectomy Using a Newly Developed Hybrid Energy Device in a Porcine Model
Journal of Endourology·2019· 1 cited
Abstract 3405: Integrated analysis of urothelial carcinoma
Molecular and Cellular Biology / Genetics·2019
Abstract 3405: Integrated analysis of urothelial carcinoma
Cancer Research·2019
page 1 of 11Next →

Frequent Co-authors

Yasunobu Hirata(28), Etsu Suzuki(23), Ryozo Nagai(20), Yukio Homma(13), Haruki Kume(11), Masataka Sata(10), Masao Omata(10), Shigeyoshi Oba(10), Tetsuo Nagano(9), Hiroshi Satonaka(9), Daisuke Nagata(8), Masao Takahashi(8), Nobuo Moriyama(7), Hiroshi Fukuhara(7), Takayuki Shindo(6), Masao Kakoki(6), Kenji Kangawa(6), Tadaichi Kitamura(6), Toshiro Fujita(6), Ryo Takeda(6)